1. OTHER TYPES OF TUMORS
1.1. GERM CELL TUMORS: these are tumors that begin in the cells that make up sperm and eggs, can occur anywhere in the body and can be benign or malignant.
1.2. NEUROENDOCRINE TUMORS: are formed from cells that secrete hormones into the blood in response to signals from the nervous system. Tumors that produce hormones in larger quantities than normal and give different clinical pictures, according to the affected hormone. They can be benign or malignant.
1.3. CARCINOID TUMORS: they are a type of neuroendocrine tumor, they are slow growing that are generally found in the gastrointestinal tract (rectum-small intestine) and can spread to the liver or other sites of the body and secrete substances such as: serotonin and prostaglandins and cause the syndrome carcinoid
2. BRAIN AND SPINAL CORD TUMORS: There are several types, cancer depends on the cell and where it originated. They can be benign and malignant tumors.
2.1. ASTROCITIC TUMOR: Astrocytes that help keep nerve cells healthy.
3. MELANOMA: It begins in the cells that become melanocytes (cells that produce melanin, the pigment that gives skin its color). Most melanomas form on the skin but can also form in the tissues of the eyes.
4. MULTIPLE MYELOMA: They begin in plasma cells (immune cells). Myeloma cells accumulate in the bone marrow and form tumors in bones throughout the body. (KOHLER disease)
4.1. Stakeholders
5. CARCINOMA: they are the most frequent types of cancer and are formed in epithelial cells.
5.1. ADENOCARCINOMA: Breast-colon-prostate cancer.
5.2. BASAL CELL CARCINOMA: begins in the lowest layer of the epidermis.
5.3. SCAMOUS CELL CARCINOMA: surface of the skin, lungs, stomach, intestines, bladder and kidneys. Known as: squamous cell carcinomas.
5.4. TRANSITIONAL CELL CARCINOMAS: these are the cells that line the bladder, ureters and renal pelvis.
6. SARCOMAS: are cancers that form in bone and soft tissue.
6.1. BONES: Osteosarcoma.
6.1.1. Revenue and P&L Forecast (5 Years)
6.1.2. Revenue should be split out quarterly
6.2. SOFT FABRICS:
6.2.1. Adipose tissue (Liposarcoma, Muscle tissue (Leiomyosarcoma), Blood vessels, Lymphatic vessels, Fibrous tissue such as tendon and lymphomas (Kaposi's sarcoma, Malignant fibrous histisitoma, protuberant dermatofibrosarcoma.
7. LEUKEMIA: are cancers that begin in the blood-forming tissues in the bone marrow and do not form solid tumors.
7.1. LYMPHOBLASTICS
7.1.1. Sharp
7.1.2. Chronicle
7.2. MYELOIDS
7.2.1. Sharp
7.2.2. Chronicle
8. LYMPHOMA: It is a cancer that begins in lymphocytes (T or B cells). They are white blood cells that fight disease and are part of the immune system. Abnormal lymphocytes collect in the lymph nodes, lymph vessels, and other organs of the body.
8.1. HODGKIN LYMPHOMA: These are specific to B cells and are called Reed-Stenberg cells.
8.1.1. Situational Analysis / Drivers
8.1.1.1. What is driving us to do this?
8.1.1.2. SWOT Analysis
8.1.1.2.1. Strengths
8.1.1.2.2. Weaknesses
8.1.1.2.3. Opportunities
8.1.1.2.4. Threats
8.1.1.3. Customer Findings - What have we learned from customers?
8.1.2. Competitive Analysis
8.1.2.1. Do we have competitors and threats in these target markets with the proposed offerings?
8.1.2.2. What are our competitors doing and how are they positioning?
8.1.2.3. How do we position against each competitor?
8.1.3. Target Customer(s)
8.1.3.1. Buyer Profile
8.1.3.1.1. Title
8.1.3.1.2. Industry
8.1.3.1.3. Geography
8.1.3.1.4. Business Size
8.1.3.2. Influencer Profile
8.1.3.3. User Profile
8.1.3.4. What do customers want and need?
8.1.3.5. What business problems do each of these customers have?
8.1.4. Customer Segmentation
8.1.4.1. Which customers or sets of customers do we sell to?
8.1.4.2. What are the target market segments that we want to go after?
8.1.4.3. What are the distinct problems for each segment of the market?
8.1.5. Total Available Market
8.1.5.1. New Prospects
8.1.5.1.1. How much of each target segment have we penetrated?
8.1.5.1.2. How much opportunity is available in each target segment?
8.1.5.2. Existing Customers
8.1.5.2.1. Can we up-sell existing customers?
8.2. NON-HODGKIN LYMPHOMA: can be formed from B or T cells, they can be fast or slow growing.
8.2.1. Service Offer
8.2.1.1. What are we selling?
8.2.1.2. Product Definition
8.2.1.3. Pricing
8.2.1.4. Packaging
8.2.1.5. Positioning
8.2.2. Value Proposition
8.2.2.1. What is the Value Proposition to the Customer?
8.2.2.2. What pain are we solving?